Quotes Takeda Pharmaceutical Company Limited BOERSE MUENCHEN
Equities
TKD
JP3463000004
Pharmaceuticals
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.06 EUR | +1.95% |
|
-2.47% | -7.07% |
06-24 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
06-24 | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Quotes 5-day view
Real-time BOERSE MUENCHEN19/06/2024 | 20/06/2024 | 21/06/2024 | 24/06/2024 | |
---|---|---|---|---|
Last | 23.5 € | 23.6 € | 23.6 € | 24.06 € |
Volume | 102 | 1 | 21 | 101 |
Change | -1.38% | +0.43% | 0.00% | +1.95% |
Opening | 23.83 | 23.57 | 23.60 | 23.85 |
High | 23.86 | 23.78 | 23.79 | 24.06 |
Low | 23.50 | 23.57 | 23.60 | 23.85 |
Performance
1 week | -2.47% | ||
Current month | -1.43% | ||
1 month | -1.31% | ||
3 months | -10.16% | ||
6 months | -6.24% | ||
Current year | -7.07% | ||
1 year | -17.88% | ||
3 years | -14.89% | ||
5 years | -21.88% | ||
10 years | -29.56% |
Volumes
marketsBasic data
Highs and lows
![Extreme 23.5](/images/extremecours_fleche.png)
![Extreme 23.5](/images/extremecours_fleche.png)
![Extreme 23.4](/images/extremecours_fleche.png)
![Extreme 23.33](/images/extremecours_fleche.png)
![Extreme 23.33](/images/extremecours_fleche.png)
Indicators
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -7.07% | ||
2023 | -10.66% | ||
2022 | +19.01% | ||
2021 | -18.32% | ||
2020 | -16.56% | ||
2019 | +21.47% | ||
2018 | -38.58% | ||
2017 | +21.94% | ||
2016 | -14.70% | ||
2015 | +34.16% | ||
2014 | +2.57% | ||
2013 | -1.01% | ||
2012 | +0.25% | ||
2011 | -7.87% | ||
2010 | +25.16% | ||
2009 | -20.44% | ||
2008 | -6.75% | ||
2007 | -24.49% | ||
2006 | +13.93% | ||
2005 | +26.34% | ||
2004 | +15.04% | ||
2003 | -19.72% | ||
2002 | -21.81% | ||
2001 | -19.68% | ||
2000 | +31.58% | ||
1999 | -22.51% |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Quotes Takeda Pharmaceutical Company Limited